<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39188069</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Duration of PCR positivity by type of respiratory virus among children using a multiplex PCR test.</ArticleTitle><Pagination><StartPage>e29890</StartPage><MedlinePgn>e29890</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29890</ELocationID><Abstract><AbstractText>Prolonged positive polymerase chain reaction (PCR) results, irrespective of the transmission risk, can lead to prolonged restrictions on daily activities and infection precaution interventions. Studies evaluating the duration of PCR positivity for multiple pathogens in a single patient cohort are scarce. This study aimed to evaluate and compare the durations of PCR positivity for multiple respiratory viruses among children and adolescents. This retrospective study was conducted between April 2018 and March 2024 using a multiplex PCR respiratory panel for symptomatic children and adolescents who had at least two tests within 90 days of study period, with the first PCR test positive. The rate and likelihood of persistent PCR positivity were evaluated for multiple respiratory viruses. For 1325 positive results, repeat tests were conducted within 90 days. The persistent PCR positivity rate at repeat testing decreased over time (60.6%, Days 1-15 and 21.7%, Days 76-90, after the first test). In multivariate logistic regression analysis, an increased likelihood of persistent PCR positivity was observed for rhinovirus/enterovirus and adenovirus, whereas decreased likelihood of persistent positivity was seen in influenza and seasonal coronaviruses, compared with parainfluenza viruses. Persistent PCR positivity is common for multiple respiratory viruses in symptomatic children.</AbstractText><CopyrightInformation>© 2024 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kitano</LastName><ForeName>Taito</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitagawa</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murata</LastName><ForeName>Masayuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onishi</LastName><ForeName>Mai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hachisuka</LastName><ForeName>Soshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okubo</LastName><ForeName>Tenshin</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Naohiro</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishikawa</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onaka</LastName><ForeName>Masayuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Rika</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekine</LastName><ForeName>Madoka</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Soma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Fumihiko</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Sayaka</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060885" MajorTopicYN="Y">Multiplex Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="N">Viruses</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">SARS‐CoV‐2</Keyword><Keyword MajorTopicYN="N">adenovirus</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">multiplex polymerase chain reaction</Keyword><Keyword MajorTopicYN="N">respiratory syncytial virus infections</Keyword><Keyword MajorTopicYN="N">respiratory tract infections</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>2</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39188069</ArticleId><ArticleId IdType="doi">10.1002/jmv.29890</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Safiri S, Mahmoodpoor A, Kolahi AA, et al. Global burden of lower respiratory infections during the last three decades. Front Public Health. 2022;10:1028525. doi:10.3389/fpubh.2022.1028525</Citation></Reference><Reference><Citation>Huh K, Kim I, Jung J, et al. Prolonged shedding of type 55 human adenovirus in immunocompetent adults with adenoviral respiratory infections. Eur J Clin Microbiol Infect Dis. 2019;38(4):793‐800. doi:10.1007/s10096-019-03471-9</Citation></Reference><Reference><Citation>Kim SM, Hwang YJ, Kwak Y. Prolonged SARS‐CoV‐2 detection and reversed RT‐PCR results in mild or asymptomatic patients. Infect Dis. 2021;53(1):31‐37. doi:10.1080/23744235.2020.1820076</Citation></Reference><Reference><Citation>Henderson DK, Weber DJ, Babcock H, et al. The perplexing problem of persistently PCR‐positive personnel. Infect Control Hosp Epidemiol. 2021;42(2):203‐204. doi:10.1017/ice.2020.343</Citation></Reference><Reference><Citation>Plebani M. Persistent viral RNA shedding in COVID‐19: caution, not fear. EBioMedicine. 2021;64:103234. doi:10.1016/j.ebiom.2021.103234</Citation></Reference><Reference><Citation>Wu Y, Guo Z, Yuan J, et al. Duration of viable virus shedding and polymerase chain reaction positivity of the SARS‐CoV‐2 Omicron variant in the upper respiratory tract: a systematic review and meta‐analysis. Int J Infect Dis. 2023;129:228‐235. doi:10.1016/j.ijid.2023.02.011</Citation></Reference><Reference><Citation>von Linstow ML, Eugen‐Olsen J, Koch A, Winther TN, Westh H, Hogh B. Excretion patterns of human metapneumovirus and respiratory syncytial virus among young children. Eur J Med Res. 2006;11(8):329‐335.</Citation></Reference><Reference><Citation>Qureshi AI, Baskett WI, Huang W, Lobanova I, Hasan Naqvi S, Shyu CR. Reinfection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in patients undergoing serial laboratory testing. Clin Infect Dis. 2022;74(2):294‐300. doi:10.1093/cid/ciab345</Citation></Reference><Reference><Citation>Government of The United Kingdom. Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination. 2021. Accessed June 16, 2024. http://www.gov.uk/government/publications/third-primary-covid-19-vaccine-dose-for-people-who-are-immunosuppressed-jcvi-advice/joint-committee-on-vaccination-and-immunisation-jcvi-advice-on-third-primary-dose-vaccination</Citation></Reference><Reference><Citation>Dolan SA, Mulcahy Levy J, Moss A, et al. SARS‐CoV‐2 persistence in immunocompromised children. Pediatr Blood Cancer. 2021;68(12):e29277. doi:10.1002/pbc.29277</Citation></Reference><Reference><Citation>de Lima CR, Mirandolli TB, Carneiro LC, et al. Prolonged respiratory viral shedding in transplant patients. Transpl Infect Dis. 2014;16(1):165‐169. doi:10.1111/tid.12167</Citation></Reference><Reference><Citation>Cheng FW, Lee V, Shing MM, Li CK. Prolonged shedding of respiratory syncytial virus in immunocompromised children: implication for hospital infection control. J Hosp Infect. 2008;70(4):383‐385. doi:10.1016/j.jhin.2008.08.014</Citation></Reference><Reference><Citation>Peltola V, Waris M, Kainulainen L, Kero J, Ruuskanen O. Virus shedding after human rhinovirus infection in children, adults and patients with hypogammaglobulinaemia. Clin Microbiol Infect. 2013;19(7):322‐327. doi:10.1111/1469-0691.12193</Citation></Reference><Reference><Citation>Mason EO Jr, Wald ER, Tan TQ, et al. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J. 2007;26(6):480‐484. doi:10.1097/INF.0b013e31805ce277</Citation></Reference><Reference><Citation>Kennedy JL, Turner RB, Braciale T, Heymann PW, Borish L. Pathogenesis of rhinovirus infection. Curr Opin Virol. 2012;2(3):287‐293. doi:10.1016/j.coviro.2012.03.008</Citation></Reference><Reference><Citation>Inagaki A, Kitano T, Nishikawa H, et al. The epidemiology of admission‐requiring pediatric respiratory infections in a Japanese community hospital using multiplex PCR. Jpn J Infect Dis. 2021;74(1):23‐28. doi:10.7883/yoken.JJID.2020.154</Citation></Reference><Reference><Citation>Howard LM, Johnson M, Gil AI, et al. Molecular epidemiology of rhinovirus detections in young children. Open Forum Infect Dis. 2016;3(1):ofw001. doi:10.1093/ofid/ofw001</Citation></Reference><Reference><Citation>Rankin DA, Spieker AJ, Perez A, et al. Circulation of rhinoviruses and/or enteroviruses in pediatric patients with acute respiratory illness before and during the COVID‐19 pandemic in the US. JAMA Netw Open. 2023;6(2):e2254909. doi:10.1001/jamanetworkopen.2022.54909</Citation></Reference><Reference><Citation>Kakee S, Mino Y, Okuno K, Kawaba D, Maejima A, Namba N. Pediatric respiratory virus infections during the COVID‐19 pandemic in a region without active severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) circulation. Yonago Acta Med. 2022;65(3):244‐253. doi:10.33160/yam.2022.08.011</Citation></Reference><Reference><Citation>Paalanne N, Honkila M, Mattila S, Pokka T, Renko M, Tapiainen T. Duration of clinical symptoms in children with acute respiratory infection. Acta Paediatr. 2023;112(4):813‐819. doi:10.1111/apa.16607</Citation></Reference><Reference><Citation>Sammons JS, Graf EH, Townsend S, et al. Outbreak of adenovirus in a neonatal intensive care unit: critical importance of equipment cleaning during inpatient ophthalmologic examinations. Ophthalmology. 2019;126(1):137‐143. doi:10.1016/j.ophtha.2018.07.008</Citation></Reference><Reference><Citation>Kampf G. Efficacy of ethanol against viruses in hand disinfection. J Hosp Infect. 2018;98(4):331‐338. doi:10.1016/j.jhin.2017.08.025</Citation></Reference><Reference><Citation>Uzuner H, Karadenizli A, Er DK, Osmani A. Investigation of the efficacy of alcohol‐based solutions on adenovirus serotypes 8, 19 and 37, common causes of epidemic keratoconjunctivitis, after an adenovirus outbreak in hospital. J Hosp Infect. 2018;100(3):30. doi:10.1016/j.jhin.2018.05.011</Citation></Reference><Reference><Citation>Zeng SZ, Xie LY, Yu T, et al. Persistent viral shedding of human adenovirus type 7 in children with severe pneumonia. J Med Virol. 2021;93(8):4846‐4855. doi:10.1002/jmv.26864</Citation></Reference><Reference><Citation>Sako A, Gu Y, Masui Y, Yoshimura K, Yanai H, Ohmagari N. Prescription of anti‐influenza drugs in Japan, 2014‐2020: A retrospective study using open data from the national claims database. PLoS One. 2023;18(10):e0291673. doi:10.1371/journal.pone.0291673</Citation></Reference><Reference><Citation>Nakajima K, Akebo H, Tsugihashi Y, Ishimaru H, Sada R. Association of physician experience with a higher prescription rate of anti‐influenza agents in low‐risk patients. Intern Emerg Med. 2021;16(5):1215‐1221. doi:10.1007/s11739-020-02570-2</Citation></Reference><Reference><Citation>Liu Y, Xu L, Piao X, et al. Epidemiological, clinical, and household transmission characteristics of children and adolescents infected with SARS‐CoV‐2 Omicron variant in Shanghai, China: a retrospective, multicenter observational study. Int J Infect Dis. 2023;129:1‐9. doi:10.1016/j.ijid.2023.01.030</Citation></Reference><Reference><Citation>Li CC, Wang L, Eng HL, et al. Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerg Infect Dis. 2010;16(8):1265‐1272. doi:10.3201/eid1608.091918</Citation></Reference><Reference><Citation>Utsunomiya T, Hibino A, Taniguchi K, et al. Factors contributing to symptom duration and viral reduction in outpatient children with respiratory syncytial virus infection. Pediatr Infect Dis J. 2020;39(8):678‐683. doi:10.1097/INF.0000000000002626</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>